ArticleViruses2023

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype.

Pierluigi Francesco Salvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.